Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma

Fig. 1

ssGSEA based on the immune system-related gene classifier and prognostic analyses. a Immune system-related gene clustering and classification of Groups 1–4. b Overall survival analyses of the four groups, with Group 4 showing the poorest prognoses. c Prognostic analysis comparing Group 1 to Group 4, showing that Group 1 had better prognoses than Group 4. d Group 2 also demonstrated longer overall survival times than Group 4. e Group 3 also demonstrated better overall prognoses than Group 4

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us